Portfolio company
Gallant Pet
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops regenerative stem cell therapies for domestic cats and dogs to treat chronic inflammatory and degenerative conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gallant Therapeutics
This company develops mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
Gallant
The company develops ready-to-use mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
BioCraft
This biotechnology company develops cell-cultured meat ingredients for pet food manufacturers to produce sustainable nutrition for cats and dogs.
Elita Pet
This company develops a health management platform and stem cell banking services for dog owners to enable proactive and personalised preventative care.
LEAH Labs
This company develops gene-edited cell therapies for dogs with cancer for use by veterinarians.
Rejuvenate Bio
The company develops gene therapies to treat age-related chronic diseases in humans and companion animals.